Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 105 of 1,261
  1. US 12043620

    Benzazole compounds and methods for making and using the compounds

    Rigel Pharmaceuticals, Inc. · Granted Jul 23, 2024 · Expires Jul 18, 2044

    granted
  2. US 12043640

    Prodrugs of STAT3 inhibitors

    Tvardi Therapeutics, Inc. · Granted Jul 23, 2024 · Expires Jul 18, 2044

    granted
  3. US 12042558

    Method and formulation for improving roflumilast skin penetration lag time

    ARCUTIS BIOTHERAPEUTICS, INC. · Granted Jul 23, 2024 · Expires Jul 18, 2044

    granted
  4. US 12042543

    Substituted 3-amino-5-phenylbenzamide compounds as covalent inhibitors of enhancer zeste homolog 2 (EZH2) and proteolysis-targeting chimeric derivatives thereof (PROTACs) that induce degradation of EZH2

    Northwestern University · Granted Jul 23, 2024 · Expires Jul 18, 2044

    granted
  5. US 12043831

    Modulation of alpha synuclein expression

    Ionis Pharmaceuticals, Inc. · Granted Jul 23, 2024 · Expires Jul 18, 2044

    granted
  6. US 12043667

    CLEC12a binding polypeptides and uses thereof

    Inhibrx Biosciences, Inc. · Granted Jul 23, 2024 · Expires Jul 18, 2044

    granted
  7. US 12042529

    Optimization of enzyme replacement therapy for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 23, 2024 · Expires Jul 18, 2044

    granted
  8. US 12043607

    HDAC inhibitors and therapeutic use thereof

    Tango Therapeutics, Inc. · Granted Jul 23, 2024 · Expires Jul 18, 2044

    granted
  9. US 12043833

    Targeted compositions

    ARBUTUS BIOPHARMA CORPORATION · Granted Jul 23, 2024 · Expires Jul 18, 2044

    granted
  10. WO 2024149832

    SARNA (VRP) MODIFIÉ RECOMBINANT POUR VACCIN CONTRE LE CANCER

    BAVARIAN NORDIC AS [DK] · Granted Jul 18, 2024 · Expires Jul 13, 2044

    granted
  11. US 12036278

    Smallpox vaccine for cancer treatment

    Calidi Biotherapeutics (Nevada), Inc. · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  12. US 12036319

    Polyvalent sting activating compositions and uses thereof

    The Board of Regents of the University of Texas System · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  13. US 12036198

    Dosage forms and therapeutic uses of L-4-chlorokynurenine

    VISTAGEN THERAPUETICS, INC. · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  14. US 12036266

    Activatable cytokine polypeptides and methods of use thereof

    Werewolf Therapeutics, Inc. · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  15. US 12036269

    Human-enzyme mediated depletion of homocysteine for treating patients with hyperhomocysteinemia and homocystinuria

    The Board of Regents of the University of Texas System · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  16. US 12036231

    Cyclic dinucleotides as agonists of stimulator of interferon gene dependent signalling

    The Board of Regents of the University of Texas System · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  17. US 12036205

    Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders

    Amazentis SA · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  18. US 12036314

    Compositions and methods for in situ-forming tissue constructs

    United States Government as represented by the Department of Veterans Affairs · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  19. US 12036194

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  20. US 12036405

    System and method of electric-induced acoustic tomography for electrotherapy monitoring

    The Board of Regents of the University of Oklahoma · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  21. US 12036225

    Use of ibezapolstat to promote microbiome health

    Acurx Pharmaceuticals, Inc. · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  22. US 12036211

    Nicorandil derivatives

    UNICYCIVE THERAPEUTICS, INC. · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  23. US 12037401

    Anti-TrkB monoclonal antibodies and methods of use

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  24. US 12035713

    Pest control using natural pest control agent blends

    TYRATECH, INC. · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.